Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
John D Gross
Affiliation
Department of Pharmaceutical Chemistry, University of California san francisco
ORCID
Career Start Year
1995
Papers
72
H Index
32
Expertise
CM4AI Collaborator
Trey Ideker (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36657879
A call to order: Examining structured domains in biomolecular condensates.
J Magn Reson
2023
36754086
The structural basis for HIV-1 Vif antagonism of human APOBEC3G.
Nature
2023
35018374
SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein.
bioRxiv
2022
35576528
Fluorescence-Based Activity Screening Assay Reveals Small Molecule Inhibitors of Vaccinia Virus mRNA Decapping Enzyme D9.
ACS Chem Biol
2022
36095012
SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein.
PLoS Pathog
2022
35290794
Structure of the poxvirus decapping enzyme D9 reveals its mechanism of cap recognition and catalysis.
Structure
2022
33439620
Structural Insights into the Interaction of Clinically Relevant Phosphorothioate mRNA Cap Analogs with Translation Initiation Factor 4E Reveal Stabilization via Electrostatic Thio-Effect.
ACS Chem Biol
2021
33767388
Biomolecular condensates amplify mRNA decapping by biasing enzyme conformation.
Nat Chem Biol
2021
33983947
Identification of recombinant Fabs for structural and functional characterization of HIV-host factor complexes.
PLoS One
2021
32513655
Pdc2/Pat1 increases the range of decay factors and RNA bound by the Lsm1-7 complex.
RNA
2020
32353859
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
Nature
2020
30575809
Publisher Correction: Structural and molecular mechanisms for the control of eukaryotic 5'-3' mRNA decay.
Nat Struct Mol Biol
2019
31690658
Pat1 activates late steps in mRNA decay by multiple mechanisms.
Proc Natl Acad Sci U S A
2019
31830442
Structural Basis for a Species-Specific Determinant of an SIV Vif Protein toward Hominid APOBEC3G Antagonism.
Cell Host Microbe
2019
32493764
Biophysical Properties of HP1-Mediated Heterochromatin.
Cold Spring Harb Symp Quant Biol
2019
31618757
HP1 reshapes nucleosome core to promote phase separation of heterochromatin.
Nature
2019
30961890
Conformational Dynamics of the HIV-Vif Protein Complex.
Biophys J
2019
29101277
Application of a <i>Schizosaccharomyces pombe</i> Edc1-fused Dcp1-Dcp2 decapping enzyme for transcription start site mapping.
RNA
2018
30166453
CRL4<sup>AMBRA1</sup> targets Elongin C for ubiquitination and degradation to modulate CRL5 signaling.
EMBO J
2018
30518847
Structural and molecular mechanisms for the control of eukaryotic 5'-3' mRNA decay.
Nat Struct Mol Biol
2018
30455174
Decapping enzymes STOP "cancer" ribosomes in their tracks.
EMBO J
2018
30308158
A Viral Protein Restricts Drosophila RNAi Immunity by Regulating Argonaute Activity and Stability.
Cell Host Microbe
2018
29618050
Control of mRNA decapping by autoinhibition.
Nucleic Acids Res
2018
29559651
Structure of the activated Edc1-Dcp1-Dcp2-Edc3 mRNA decapping complex with substrate analog poised for catalysis.
Nat Commun
2018
29304101
Fab-based inhibitors reveal ubiquitin independent functions for HIV Vif neutralization of APOBEC3 restriction factors.
PLoS Pathog
2018
28002405
Molecular biology: Messenger RNAs marked for longer life.
Nature
2017
28104838
Distortion of histone octamer core promotes nucleosome mobilization by a chromatin remodeler.
Science
2017
28299671
CBFÿ and HIV Infection.
Adv Exp Med Biol
2017
28942089
Biochemical Basis for Distinct Roles of the Heterochromatin Proteins Swi6 and Chp2.
J Mol Biol
2017
28961413
Making Sense of Multifunctional Proteins: Human Immunodeficiency Virus Type 1 Accessory and Regulatory Proteins and Connections to Transcription.
Annu Rev Virol
2017
26826132
Two-headed tetraphosphate cap analogs are inhibitors of the Dcp1/2 RNA decapping complex.
RNA
2016
27694842
Structural basis of mRNA-cap recognition by Dcp1-Dcp2.
Nat Struct Mol Biol
2016
25981045
Lineage-Specific Viral Hijacking of Non-canonical E3Â Ubiquitin Ligase Cofactors in the Evolution of Vif Anti-APOBEC3 Activity.
Cell Rep
2015
26422686
Thermodynamics of Rev-RNA interactions in HIV-1 Rev-RRE assembly.
Biochemistry
2015
24904166
A mutually assured destruction mechanism attenuates light signaling in Arabidopsis.
Science
2014
23352243
From systems to structure: bridging networks and mechanism.
Mol Cell
2013
23911090
Active site conformational dynamics are coupled to catalysis in the mRNA decapping enzyme Dcp2.
Structure
2013
23728292
The glucocorticoid receptor dimer interface allosterically transmits sequence-specific DNA signals.
Nat Struct Mol Biol
2013
23582258
Judge, jury, and executioner: DXO functions as a decapping enzyme and exoribonuclease in pre-mRNA quality control.
Mol Cell
2013
23333304
CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression.
Mol Cell
2013
22323607
Interdomain dynamics and coactivation of the mRNA decapping enzyme Dcp2 are mediated by a gatekeeper tryptophan.
Proc Natl Acad Sci U S A
2012
23300442
Inhibition of a NEDD8 Cascade Restores Restriction of HIV by APOBEC3G.
PLoS Pathog
2012
22760860
The crystal structure of the periplasmic domain of Vibrio parahaemolyticus CpxA.
Protein Sci
2012
21148770
Dcp1 links coactivators of mRNA decapping to Dcp2 by proline recognition.
RNA
2011
22190037
Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection.
Nature
2011
20086104
Identification and analysis of the interaction between Edc3 and Dcp2 in Saccharomyces cerevisiae.
Mol Cell Biol
2010
20799348
The crystal structure Escherichia coli Spy.
Protein Sci
2010
20711189
A split active site couples cap recognition by Dcp2 to activation.
Nat Struct Mol Biol
2010
20400949
Cricket paralysis virus antagonizes Argonaute 2 to modulate antiviral defense in Drosophila.
Nat Struct Mol Biol
2010
19389408
An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model.
J Mol Biol
2009
1 - 50 of 72
Column Actions
Search
Recommended Authors
Soumya Ranganathan
and Blood Institute, National Institutes of Health
Career Start Year
2014
Number of shared co-authors
0
Paul Dominic B Olinares
The Rockefeller University
Career Start Year
2009
Number of shared co-authors
1
Kelly R Molloy
The Rockefeller University
Career Start Year
2006
Number of shared co-authors
1
Lisa M Miller Jenkins
National Cancer Institute, National Institutes of Health
Career Start Year
2005
Number of shared co-authors
1
Ajay A Vashisht
David Geffen School of Medicine, University of California los angeles
Career Start Year
2005
Number of shared co-authors
4
Yuliya Gordiyenko
University of Oxford
Career Start Year
2004
Number of shared co-authors
1
Christopher C Ebmeier
University of Colorado
Career Start Year
2004
Number of shared co-authors
4
Ludivine Wacheul
Universite libre de Bruxelles (ULB)
Career Start Year
2001
Number of shared co-authors
1
Andrew P VanDemark
University of Pittsburgh
Career Start Year
2000
Number of shared co-authors
1
Guillaume M Hautbergue
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year
1999
Number of shared co-authors
2
May Khanna
College of Dentistry, New York University
Career Start Year
1999
Number of shared co-authors
1
Jan P Erzberger
UT Southwestern Medical Center
Career Start Year
1998
Number of shared co-authors
2
Andres Ramos
Institute of Structural and Molecular Biology (ISMB), University College London
Career Start Year
1997
Number of shared co-authors
4
James A Wohlschlegel
David Geffen School of Medicine, University of California Los Angeles
Career Start Year
1996
Number of shared co-authors
4
Yun Bai
Carnegie Institution for Science
Career Start Year
1996
Number of shared co-authors
3
Dylan J Taatjes
University of Colorado
Career Start Year
1996
Number of shared co-authors
2
Andreas Bracher
Max-Planck-Institute of Biochemistry
Career Start Year
1995
Number of shared co-authors
2
Torben Heick Jensen
Universitetsbyen 81, Aarhus University
Career Start Year
1995
Number of shared co-authors
0
Christopher D Lima
Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center
Career Start Year
1993
Number of shared co-authors
1
Maria R Conte
King's College London
Career Start Year
1993
Number of shared co-authors
4
Michael Sattler
Technical University of Munich, Institute of Structural Biology
Career Start Year
1991
Number of shared co-authors
4
Cheryl H Arrowsmith
University of Toronto
Career Start Year
1989
Number of shared co-authors
8
Liang Tong
Columbia University
Career Start Year
1988
Number of shared co-authors
4
Jennifer A Doudna
Innovative Genomics Institute, University of California berkeley
Career Start Year
1987
Number of shared co-authors
41
Aled M Edwards
University of Toronto
Career Start Year
1984
Number of shared co-authors
8
Opher Gileadi
Structural Genomics Consortium Karolinska Institute Stockholm Sweden.
Career Start Year
1984
Number of shared co-authors
2
Henning Urlaub
Max Planck Institute for Multidisciplinary Sciences
Career Start Year
1982
Number of shared co-authors
3
Stephen K Burley
The State University of New Jersey
Career Start Year
1982
Number of shared co-authors
8
Pamela A Silver
Harvard Medical School
Career Start Year
1979
Number of shared co-authors
2
Alain Laederach
University of North Carolina at Chapel Hill
Career Start Year
1972
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers
10
Dong Young Kim
Seoul National University College of Medicine, Seoul National University Hospital
Co-authored papers
8
Stephen N Floor
University of California san francisco
Co-authored papers
8
David J Stanley
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers
6
Jennifer M Binning
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers
5
Eunju Kwon
Yeungnam University
Co-authored papers
5
Charles S Craik
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers
5
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Co-authored papers
4
Alma L Burlingame
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers
4
Reuben S Harris
University of Texas Health San Antonio
Co-authored papers
4
Geeta J Narlikar
University of California san francisco
Co-authored papers
4
Alan D Frankel
University of California san francisco
Co-authored papers
3
Lily Burton
University of Chicago
Co-authored papers
3
Melanie Ott
Gladstone Institute of Virology
Co-authored papers
3
Ming Li
Department of Cancer Research Institute, University of South Australia
Co-authored papers
3
Michael J Trnka
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers
3
James S Fraser
University of California san francisco
Co-authored papers
3
Yifan Cheng
Quantitative Bioscience Institute, University of California san francisco
Co-authored papers
3
Michael Emerman
Fred Hutchinson Cancer Center
Co-authored papers
3
Eric Verdin
Buck Institute for Research on Aging
Co-authored papers
3
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers
2
Marius Walter
Buck Institute for Research on Aging
Co-authored papers
2
Stefanie J??ger
Institute of Molecular Biosciences, Goethe University Frankfurt
Co-authored papers
2
Birgit Schilling
Buck Institute for Research on Aging
Co-authored papers
2
Jeffrey R Johnson
Gladstone Institutes
Co-authored papers
2
David E Gordon
Emory University
Co-authored papers
2
Boris Matija Peterlin
University of California at San Francisco
Co-authored papers
2
Carol A Gross
University of California san francisco
Co-authored papers
2
Kathleen E Franks-Skiba
University of California, USA Quantitative Biosciences Institute (QBI) san francisco
Co-authored papers
2
Hiroshi Matsuo
Frederick National Laboratory for Cancer Research
Co-authored papers
2
1 - 30